| Individualized | Fixed | p | |
|---|---|---|---|
| Number of patients (n) | 58 | 112 | |
| Age at transplant (years) | 7.4 (2.8-13.2) | 6.5 (2.1-12.4) | 0.97 |
| Starting day of ATG (days before HCT) | 9 (9-9) | 4.2 (4-5) | <0.05 |
| Cumulative dose of ATG (mg/kg) | 9 (6-10) | 10 (9.8-10.2) | <0.05 |
| Graft source: marrow and peripheral blood | 29 (50) | 70 (62) | <0.05 |
| Graft source: cordblood | 29 (50) | 42 (38) | |
| Diagnosis: malignancy | 21 (36) | 46 (41) | <0.05 |
| Fully Matched Graft [n(%)] | 38 (66) | 60 (54) | 0.17 |
| Median (IQR) unless otherwise specified |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.